InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: None

Saturday, 11/01/2014 4:32:28 PM

Saturday, November 01, 2014 4:32:28 PM

Post# of 403754
Anyone want to weigh in on efficacy with Brilacidin 2b bottom line results and its effect on the price per share? Looking at the phase 2a (link below) I am guesstimating that the better of the two 1 day treatments will be in the low 90's for 28 day sustained response. I think 90-93% will be par for the course and confirmation of results will drive us up to $4.00. Anything in the 94-96% range being above expectations pushing us closer to $5 and anything over 96% being well beyond expectations taking us to???

I don't believe any of Brilacidins short treatments will reach Dapto at ~98% nor does need to. We will get the bottom line data in the coming weeks but I was curious what others are expecting...market expectations perhaps not so much on pps but on efficacy?

EAT YOUR BROCCOLI!


http://files.shareholder.com/downloads/ABEA-4ITCYZ/1997024712x0x611205/FEA66C67-D02F-4FF2-B230-AA711F46ED7F/PMX-30063_Antibiotic_Fact_Sheet_Nov_2012_.pdf